NCT02050503View on ClinicalTrials.gov

Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Breakthrough PainMucositisRadiotherapyChemotherapyHead and Neck Cancer
Trial Locations (1)

28220

Alejandro de la Torre. Hospital Puerta de Hierro, Majadahonda

All Listed Sponsors
lead

Grupo de Investigación Clínica en Oncología Radioterapia

OTHER

NCT02050503 - Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis | Biotech Hunter | Biotech Hunter